Christopher Visioli

Director of Finance/CFO at POPULATION HEALTH INVESTMENT CO., INC.

48 year

Consumer Services

Health Technology

Finance

Profile

Mr. Christopher Visioli is a Chief Financial Officer at Population Health Investment Co., Inc. and a Chief Financial & Accounting Officer at The Medicines Co. Mr. Visioli was previously employed as a Senior Vice President-Financial Strategy by The Medicines Co. He received his undergraduate degree from Cornell University and an MBA from Columbia Business School.

Christopher Visioli active positions

Companies	Position	Start
POPULATION HEALTH INVESTMENT CO., INC.	Director of Finance/CFO	10/09/2020

All active positions of Christopher Visioli

Former positions of Christopher Visioli

Companies	Position	End
THE MEDICINES COMPANY	Director of Finance/CFO	30/04/2020

See the detail of Christopher Visioli's experience

Training of Christopher Visioli

Cornell University	Undergraduate Degree
Columbia Business School	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher Visioli's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
The Medicines Co. The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ.	Health Technology
Population Health Investment Co., Inc. Population Health Investment Co., Inc. Financial ConglomeratesFinance Population Health Investment Co., Inc. operates as a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase and reorganization or similar business combination with one or more businesses. It intends to focus on companies in the healthcare industry such as the therapeutics sector. The company was founded by Clive A. Meanwell and Ian C. Read on September 11, 2020 and is headquartered in New York, NY.	Finance

Private companies